Akèy › Pwoblèm Je Dyabetik › Texas
Etid klinik pou Pwoblèm Je Dyabetik nan Texas
4 etid pou Pwoblèm Je Dyabetik ap chèche patisipan nan sit nan Texas.
Tèks ofisyèl etid la (Anglè)
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
- Austin Retina Associates ( Site 0008), Austin
- Retina Consultants of Texas ( Site 0001), Bellaire
- Retina Consultants of Texas ( Site 0029), Schertz
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07705555A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)
- Texas Retina ( Site 0051), Arlington
- Texas Retina Associates ( Site 0055), Fort Worth
- Retina Consultants of Texas - Katy/Cinco Ranch ( Site 0100), Katy
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07705607Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
- Austin Research Center for Retina /ID# 276101, Austin
- Star Retina /ID# 276513, Burleson
- Texas Retina Associates - Dallas /ID# 276117, Dallas
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07592273A Randomized, Phase 2 Study of Oral BGE-102 in Participants With Center-Involved Diabetic Macular Edema
- Site 106, McAllen
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 10, 2026 · NCT07812090Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.